Anxiety Disorders at Psych Congress 2026

5 sessions on anxiety disorders · September 15–19, 2026, New Orleans, LA. Compare anxiety disorders at other meetings →

Wednesday, September 16

Lecture · ADHD
ADHD With Comorbidities: Anxiety, Mood Disorders, Autism, and Substance Use Disorders
Timothy E. Wilens
Frameworks for diagnostic clarification and treatment sequencing when ADHD co-occurs with anxiety, mood disorders, autism, or substance use, balancing symptom control against misuse and destabilization risks.
ADHD · Autism & Neurodevelopmental Disorders · Substance Use Disorders

Symposium · First-Line Decisions
First-Line Decisions: Lifestyle Modification or Medication? Guiding Initial Care in Generalized Anxiety Disorder
Manish Jha · Saundra Jain · Vanessa Joy Walker
Helps clinicians decide between pharmacotherapy and CBT, mindfulness, sleep, and exercise strategies at the outset of GAD treatment based on severity, comorbidity, trauma history, and preference.
Lifestyle & Integrative Psychiatry · Psychotherapy
Symposium · Neurodevelopmental Disorders
Practical Management of Autism and Co-Occurring Psychiatric Conditions
Kristin Sohl · Jo Hughes
Integrated framework for assessing and treating anxiety, ADHD, and mood disorders in autistic children, including evidence-based medication use, behavioral therapy, and family engagement.
ADHD · Autism & Neurodevelopmental Disorders · Child & Adolescent
Symposium · Anxiety Disorders
When Anxiety Persists: Evidence-Based Strategies and Novel Pharmacologic Options Beyond First-Line Treatment
Rakesh Jain · Manish Jha
Step-by-step framework for treatment-resistant anxiety after SSRI/SNRI failure, covering sequencing, psychotherapy integration, and off-label and emerging agents from gabapentinoids to glutamatergic and GABAergic options.
Drug Pipeline & Clinical Trials · Psychotherapy

Symposium · MasterClass
MasterClass: GAD Care Reimagined: Current Best Practices and the Emerging Role of Psychedelics
Brittany Albright · Andrew Penn
Pairs a review of current GAD standards of care with the therapeutic rationale and emerging evidence for investigational psychedelic compounds in anxiety.
Psychedelics